Primary IgA nephropathy is more severe in TGF-β1 high secretor patients

Journal of Nephrology

Volumn 22, Issue 6, 2009, Pages 747-759

  Brezzi, Brigida ^a   Del Prete, Dorella ^b   Lupo, Antonio ^a   Magistroni, Riccardo ^c   Gomez Lira, Macarena ^d   Bernich, Patrizia ^a   Anglani, Franca ^b   Mezzabotta, Federica ^b   Turco, Alberto ^d   Furci, Luciana ^c   Ceol, Monica ^b   Bonfante, Luciana ^e   D'Angelo, Angela ^b   Albertazzi, Alberto ^c   Gambaro, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e General Hospital of Feltre   (Italy)

Author keywords

Codon 10 polymorphism; ESRD; IgA nephropathy; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CLONIDINE; COLLAGEN TYPE 4; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ALLELE; ARTICLE; BILIARY EXCRETION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL FLUID; INTERSTITIUM; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PHENOTYPE; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; BIOPSY; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; ITALY; KAPLAN-MEIERS ESTIMATE; KIDNEY; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; YOUNG ADULT;

EID: 72149087957     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. D'Amico G, Imbasciati E, Barbiano, et al. Idiopathic IgA nephropathy. Clinical and histological study of 374 patients. Medicine. 1985;64:49-60.
2. Yoshikawa N, Iijima K, Matsuyama S, et al. Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol. 1990;33:160-167.
3. Hotta O, Furuta T, Chiba S, et al. Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis. 2002;39:493-502.
4. Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis. 1997;29:526-532.
5. Bantis C, Heering PJ, Aker S, et al. Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int. 2004;66:288-294.
6. Narita I, Goto S, Saito N, et al. Genetic polymorphism of NPHS1 modifies the clinical manifestations of Ig A nephropathy. Lab Invest. 2003;83:1193-1200.
7. Kovács TJ, Harris S, Vas TK, et al. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy. J Nephrol. 2006;19:732-738.
8. Syrjanen J, Hurme M, Lehtimaki T, et al. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int. 2002;61:1079-1085.
9. Narita I, Saito N, Goto S, et al. Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int. 2002;61:1853-1858.
10. Hsu SI, Ramirez SB, Winn MP, et al. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int. 2000;57:1818-1835.
11. Wiwanitkit V. Angiotensin-converting enzyme gene polymorphism is correlated to the progression of disease in patients with IgA nephropathy: a meta-analysis. Ren Fail. 2006;28:697-699.
12. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
13. Okuda S, Languino LR, Ruoslahti E, et al. Elevated expression of transforming growth factor beta and proteoglycan production in experimental glomerulonephritis: possible role in expansion of the mesangial extracellular matrix. J Clin Invest. 1990;86:453-462.
14. Roberts AB, McCune BK, Sporn MB. TGF beta regulation of extracellular matrix. Kidney Int. 1992;41:557-559.
15. Yamamoto T, Noble NA, Miller DE, et al. Sustained expression of TGF beta 1 underlies development of progressive kidney fibrosis. Kidney Int. 1994;45:916-927.
16. Wahl SM. Transforming growth factor beta in inflammation: a cause and a cure. J Clin Immunol. 1992;12:61-74.
17. Border WA, Okuda S, Languino LR, et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature. 1990;346:371-374.
18. Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor beta 1 protects against scarring in experimental kidney diseases. Nature. 1992;360:361-364.
19. Watanabe Y, Kinoshita A, Yamada T, et al. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway. J Hum Genet. 2002;47(Suppl 9):S478-S83.
20. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor beta 1 gene in relation to myocardial infarction and blood pressure. The ECTIM study. Hypertension. 1996;28:881-887.
21. El-Gamel A, Awad MR, Hasleton PS, et al. TGF beta 1 genotype and lung allograft fibrosis. J Heart Lung Transplant. 1999;18:517-523.
22. Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor beta 1 gene. Association with transforming growth factor beta 1 production, fibrosis lung disease and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014-1020.
23. Arkwright PD, Laurie S, Super M, et al. TGF-beta 1 genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax. 2000;55:459-462.
24. Wang H, Mengsteab S, Tag CG, et al. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol. 2005;11:1929-1936.
25. Cotton SA, Gbadegesin RA, Williams S, et al. Role of TGF beta 1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int. 2002;61:61-67.
26. Akai Y, Sato H, Ozaki H, et al. Association of transforming growth factor beta 1 T29C polymorphism with the progression of diabetic nephropathy. Am J Kidney Dis. 2001;38(Suppl 1):S182-S185.
27. Wong TY, Poon P, Chow KM, et al. Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese. Kidney Int. 2003;63:1831-1835.
28. Patel A, Scott WR, Lympany PA, et al. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. Diabet Med. 2005;22(Suppl 1):S69-S73.
29. Van de Wetering J, Weimar CH, Balk AH, et al. The impact of transforming growth factor-beta1 gene polymorphism on end-stage renal failure after heart transplantation. Transplantation. 2006;82:1744-1748.
30. Chow KM, Szeto CC, Poon P, et al. Transforming growth factor-beta1 gene polymorphism in renal transplant recipients. Ren Fail. 2005;27(Suppl 6):S671-S675.
31. Lim CS, Kim YS, Chae DW, et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol. 2005;63:61-67.
32. Carturan S, Roccatello D, Menegatti E, et al. Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy. J Nephrol. 2004;17:786-789.
33. Sato F, Narita I, Goto S, et al. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens. 2004;64:35-44.
34. Del Prete D, Gambaro G, Lupo A, et al. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int. 2003;64:149-159.
35. Lee SM. Prognostic indicators of progressive renal disease in IgA nephropathy: emergence of a new histologic grading system. Am J Kidney Dis. 1997;29:953-958.
36. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215-1219.
37. Del Prete D, Forino M, Gambaro G, et al. A comparative kinetic RT/PCR strategy for the quantitation of m-RNAs in microdissected human renal biopsy specimens. Exp Nephrol. 1998;6:563-567.
38. Ketteler M, Noble NA, Border WA. Increased expression of transforming growth factor beta in renal disease. Curr Opin Nephrol Hypertens. 1994;3:446-452.
39. Honkanen E, Teppo AM, Tornroth T, et al. Urinary TGFbeta 1 in membranous glomerulonephritis. Nephrol Dial Transplant. 1997;12:2562-2568.
40. Murakami K, Takemura T, Hino S, et al. Urinary transforming growth factor beta in patients with glomerular diseases. Pediatr Nephrol. 1997;11:334-336.
41. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta 1. Hum Mol Genet. 1999;8:93-97.
42. Iwano M, Kubo A, Nishino T, et al. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int. 1996;49:1120-1126.
43. Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002;13:2600-2610.
44. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA. 1987;84:5788-5792.
45. Melk A, Henne T, Kollmar T, et al. Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. Kidney Int. 2003;64(Suppl 1):S314-S320.
46. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol. 2005;18:503-512.
47. Magistroni R, Furci L, Leonelli M, et al. A validated model of disease progression in IgA nephropathy. J Nephrol. 2006;19:32-40.
48. Li B, Khanna A, Sharma V, et al. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension. 1999;33:271-275.
49. Yamada Y, Ando F, Niino N, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals. J Hum Genet. 2002;47:243-248.
50. Freedman BI, Beck SR, Rich SS, et al; the HyperGEN Investigators. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension. 2003;42:291-296.
51. Schulz A, Litfin A, Kossmehl P, Kreutz R. Genetic dissection of increased urinary albumin excretion in the Munich Wistar Fromter rat. J Am Soc Nephrol. 2002;13:2706-2714.
52. Nonaka Takahashi S, Fujita T, et al. TGF-beta1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy. J Nephrol. 2008;21:53-63.